The accuracy of two newer generation theoretical intraocular lens (IOL) power calculation formulas and of the empirical SRK I and II formulas was evaluated in a series of 500 IOL implantations including a series of unusually long and short eyes. The prediction error of the theoretical formulas was found to be largely unaffected by the variation in axial length and corneal power, while the prediction of the SRK I formula was less accurate in the short and long eyes. The prediction of the SRK II formula was more accurate than the SRK I in that no systematic offset error with axial length could be demonstrated. However, because of a relatively larger scatter in the long eyes and a significant bias with the corneal power, the absolute error of the SRK II formula was higher than that of the theoretical formulas in the long eyes. The higher accuracy of the newer generation theoretical formulas was attributed to their improved prediction of the pseudophakic anterior chamber depth.
The postoperative intraocular lens (IOL) chamber depth was predicted using a multiple linear regression analysis of the postoperative chamber depth as a function of the corneal height, the preoperative chamber depth, and the axial length in 279 patients with a posterior chamber lens implant. Based on a linear regression formula incorporating these preoperatively defined parameters, the postoperative IOL chamber depth could be predicted with a correlation coefficient of 0.71 and an error of +/- 0.30 mm (SD). It is concluded that an individual prediction of the IOL chamber depth will improve the accuracy in IOL calculation.
Intraocular pressure (IOP) was measured before and 6, 24, 48 and 72 h after extracapsular cataract extraction with implantation of a posterior chambers lens in 3 groups of patients. Group I (30 patients): Sodium hyaluronate (Healon) was used during anterior capsulotomy and lens implantation and was aspirated at the end of surgery. Group II (22 patients): Healon as in group I + 500 mg acetazolamide at the end of surgery. Group III (17 patients): BSS and/or air was used instead of Healon during surgery. In all groups statistically significant rises in IOP after 6 h were followed by significant falls in the remaining post-operative period. The rise and subsequent fall in IOP was significantly greater in group I than in group III. Acetazolamide in group II did not prevent excessive rises in IOP. Aspiration probably shortens the period of Healon-induced hypertension. We recommend a meticulous aspiration of Healon at the end of surgery.
The predictability of a theoretical, computerized (PC-assisted) intraocular lens (IOL) power calculation method and of the Sanders-Retzlaff-Kraff [SRK] I and II methods was evaluated from preoperative and postoperative biometry in 202 cataractous patients who had extracapsular cataract extraction (ECCE). The theoretical method resulted in the lowest range and standard deviation of the error, and the highest correlation coefficient between the observed and the predicted refraction (P less than .05). The superiority of the theoretical approach was most clearly demonstrated when the postoperative measurements were used in the predictions (P less than .001). This demonstrated the potential accuracy of the formula used and the importance of incorporating methods to predict the IOL position after surgery. If the prediction of the IOL chamber depth was properly corrected for the axial length dependence, a high prediction accuracy could be obtained in short as well as in long eyes.
The mechanical quality of the diathermic capsulotomy edge is significantly less than that of the capsulorhexis edge, which indicates that the diathermic capsulotomy edge would withstand less surgical manipulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.